Development and validation of stability-indicating hplc methods for quantitative determination of pravastatin, fluvastatin, atorvastatin, and rosuvastatin in pharmaceuticals

Analytical Letters

Volumn 42, Issue 12, 2009, Pages 1784-1804

  Gomes, Fábio Pereira ^a   Garcia, Pedro López ^a   Porto Alves, João Marcel ^a   Singh, Anil Kumar ^a   Kedor Hackmann, Erika Rosa Maria ^a   Santoro, Maria Iněs Rocha Miritello ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Method validation; Pharmaceuticals; Stability indicating RP HPLC; Statins

Indexed keywords

EID: 70449378435     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710903060669     Document Type: Article

References (50)

1. Al-Rawithi, S., R. F. Hussein, and A. Alzahrani. 2003. Sensitive assay for the determination of fluvastatin in plasma utilizing high-performance liquid chromatography with fluorescence detection. Ther. Drug Monit. 25: 88-89.
2. Altuntas, T. G., and N. Erk. 2004. Liquid chromatographic determination of atorvastatin in bulk drug, tablets, and human plasma. J. Liq. Chromatogr. Relat. Technol. 27: 83-93.
3. Bahrami, G., M. Bahareh, M. Shahla, and K. Amir. 2005. Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection. J. Chromatogr. B 826: 41-45.
4. Bauer, S., J. Mwinyi, A. Stoeckle, T. Gerloff, and I. Roots. 2005. Quantification of pravastatin in human and urine after solid phase extraction using high performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 818: 257-262.
5. Bolton, S. 1990. Pharmaceutical Statistics: Practical and Clinical Application, 3rd ed. New York: Marcel Dekker.
6. Borek-Dohalsky, V., J. Huclova, B. Barrett, B. Nemec, I. Ulc, and I. Jelinek. 2006. Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study. Anal. Bioanal. Chem. 386: 275-285.
7. Brunton, L. L., J. S. Lazo, K. L. Parker. 2007. Goodman & Gilman: As bases farmacológicas da terapêutica, 11th Ed. Rio de Janeiro: McGraw-Hill.
8. Chaudhari, B. G., P. N. Manilal, and S. P. Bhagvatiprasad. 2007. Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products. Chem. Pharm. Bull. 55: 241-246.
9. Di Pietro, G., D. B. Coelho, E. Barbosa, G. T. Magalhães, M. P. Marques, and V. L. Lanchote. 2006. Chiral evaluation of fluvastatin in human plasma by high-performance liquid chromatography electrospray mass spectrometry. J. Chromatogr. B 832: 256-261.
10. Erk, N. 2003. Extractive spectrophotometric determination of atorvastatin in bulk and pharmaceutical formulations. Anal. Lett. 36: 2699-2711.
11. Ertuerk, S., S. A. Esra, E. Lale, and F. Samiye. 2003. An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets. J. Pharm. Biomed. Anal. 33: 1017-1023.
12. Feng, Y., L. Zhihe, W. Xuejun, J. Wenqing, and Z. Ding. 2003. Determination of atorvastatin calcium and its related substances by CZE. Zhongguo Yaoxue Zazhi 38: 456-458.
13. Freddy, H., and V. Chaudhari. 2005. Simultaneous determination of atorvastatin calcium and amlodipine besylate from pharmaceutical formulation by reversed phase high performance liquid chromatography. Asian J. Chem. 17: 2502-2508.
14. Gao, J., D. Zhong, D. Xiaotao, and C. Xiaoyan. 2007. Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of rosuvastatin in human plasma: Application to a pharmacokinetic study. J. Chromatogr. B 856: 35-40.
15. Grahek, R., D. Milivojevic, A. Bastarda, and M. Kracun. 2001. Chromatographic purification of some 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. J. Chromatogr. A 918: 319-324.
16. Hermann, M., H. Christensen, and J. L. B. Reubsaet. 2005. Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS. Anal. Bioanal. Chem. 382: 1242-1249.
17. International Conference on Harmonization. 2005. Guidance for Industry: ICH-Q2R1: Validation of Analytical Procedures: Methodology for Validation of Analytical Methods. ICH. http://www.ich.org/LOB/media/MEDIA417.pdf
18. Jain, K. S., M. K. Kathiravan, T. S. Somani, and C. J. Shishoo. 2007. The biology and chemistry of hyperlipidemia. Bioorg. Med. Chem. 15: 4674-4699.
19. Khan, M. R., and D. Jain. 2006. Simultaneous spectrophotometric determination of atorvastatin calcium and amlodipine besylate in tablets. Indian J. Pharm. Sci. 68: 546-548.
20. Klick, S., P. G. Muijselaar, J. Waterval, T. Eichinger, C. Korn, T. K. Gerding, A. J. Debets, C. S. Griend, C. V. D. Beld, G. W. Somsen, and G. J. De Jong. 2005. Stress testing of drug substances and drug products. Pharm. Technol. 48-66.
21. iKocijan, A., R. Grahek, A. Bastarda, and L. Zupancic-Kralj. 2005. Fast analysis of pravastatin in production media. J. Chromatogr. B 822: 311-315.
22. Krishna, M. V., and D. G. Sankar. 2006. Spectrophotometric methods for the determination of rosuvastatin calcium in pure form and in pharmaceutical formulations by using redox/complexation reactions. Pharm. Rev. 5: 164-166.
23. Krishna, M. V., and D. G. Sankar. 2007. Extractive spectrophotometric methods for the determination of rosuvastatin calcium in pure form and in pharmaceutical formulations by using safranin O and methylene blue. E-J. Chem. 4: 46-49.
24. Kumar, T. R., N. R. Shitut, P. K. Kumar, M. C. Vinu, V. V. Kumar, R. Mullangi, and N. R. Srinivas. 2006. Determination of rosuvastatin in rat plasma by HPLC: Validation and its application to pharmacokinetic studies. Biomed. Chromatogr. 20: 881-887.
25. Lan, K., X. Jiang, Y. Li, L. Wang, J. Zhou, Q. Jiang, and L. Ye. 2007. Quantitative determination of rosuvastatin in human plasma by ion pair liquid-liquid extraction using liquid chromatography with electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal. 44: 540-546.
26. Mehta, T. N., A. K. Patel, G. M. Kulkarni, and G. Suubbaiah. 2005. Determination of rosuvastatin in the presence of its degradation products by a stabilityindicating LC method. J. AOAC Int. 88: 1142-1147.
27. Mohammadi, A., N. Rezanour, A. Dogaheh, G. Bidkorbeh, M. Hashem, and R. B. Walker. 2007. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. J. Chromatogr. B 846: 215-221.
28. Nirogi, R. V. S., V. N. Kandikere, W. Shrivastava, K. Mudigonda, and P. V. Datla. 2006. Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of fluvastatin in human plasma: Validation and its application to pharmacokinetic studies. Rapid Commun. Mass Spectrom. 20: 1225-1230.
29. Onal, A., and O. Sagirli. 2006. Development of a selective LC method for the determination of pravastatin sodium. Chromatographia 64: 157-162.
30. Oudhoff, K. A., T. Sangster, E. Thomas, and I. D. Wilson. 2006. Application of microbore HPLC in combination with tandem MS for the quantification of rosuvastatin in human plasma. J. Chromatogr. B 832: 191-196.
31. Prabhakar, B. K., M. Shobha, and R. S. Appala. 2005. Spectrophotometric determination of atorvastatin in pharmaceutical formulations. Int. J. Chem. Sci. 3: 37-40.
32. Puratchikody, A., R. Valarmathy, S. P. Varghese, and J. J. Rukumani. 2003. Reverse phase-high performance liquid chromatographic determination of atorvastatin calcium in solid dosage forms. Pharm. Rev. 1: 79-83.
33. Rajeswari, K. R., G. G. Sankar, A. L. Rao, and J. V. L. N. Seshagirirao. 2006. RP-HPLC method for the simultaneous determination of atorvastatin and amlodipine in tablet dosage form. Indian J. Pharm. Sci. 68: 275-277.
34. Rajkondawar, V. V. 2006. Simultaneous estimation of rosuvastatin and ezetimibe by reverse phase high performance liquid chromatography. Asian J. Chem. 18: 3230-3232.
35. Rani, B. S., and P. V. Reddy. 2006. Estimation of pravastatin sodium in tablets by HPLC. Acta Cien. Indica. Chem. 32: 409-412.
36. Rao, Y. S., G. Haritha, P. N. Tara, K. P. R. Chowdary, and J. V. L. N. S. Rao. 2003. Estimation of pravastatin sodium by spectrophotometric method. Int. J. Chem. Sci. 1: 368-370.
37. Salem, H., G. G. Ragab, A. E. Saif, and A. Aboul-Kheir. 2006. Selective spectrophotometric determination of atorvastatin. Mansoura J. Pharm. Sci. 22: 87-101.
38. Shah, D. A., K. K. Bhatt, M. B. Shankar, R. S. Mehta, T. R. Gandhi, and S. L. Baldania. 2006. RP-HPLC determination of atorvastatin calcium and amlodipine besylate combination in tablets. Indian J. Pharm. Sci. 68: 796-799.
39. Singh, S. S., K. Sharma, H. Patel, M. Jain, H. Shah, S. Gupta, P. Thakkar, N. Patel, S. P. Singh, and B. B. Lohray. 2005. Estimation of rosuvastatin in human plasma by HPLC tandem mass spectroscopic method and its application to bioequivalence study. J. Braz. Chem. Soc. 16: 944-950.
40. Snyder, L. R., J. J. Kirkland, and J. L. Glajch. 1997. Practical HPLC Method Development, 2nd ed. New York: Wiley Interscience.
41. Sonawane, S. S., A. A. Shirkhedkar, R. Fursule, and S. Sanjay. 2006. Application of UV-spectrophotometry and RP-HPLC for simultaneous determination of atorvastatin calcium and ezetimibe in pharmaceutical dosage form. Eurasian J. Anal. Chem. 1: 31-41.
42. Stanisz, B., and K. Lukasz. 2006. Validation of HPLC method for determination of atorvastatin in tablets and for monitoring stability in solid phase. Acta Pol. Pharm. 63: 471-476.
43. Trivedi, R. K., R. R. Kallem, R. Mullagi, and N. R. Srinvas. 2005. Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: Assay development, validation, and application to a clinical study. J. Pharm. Biomed. Anal. 39: 661-669.
44. Um, S. Y., S. H. Jung, S. J. Jung, J. I. Kim, S. Y. Chung, H. J. Lee, S. B. Han, and S. O. Choi. 2005. Column-switching high-performance liquid chromatographic analysis of fluvastatin in rat plasma by direct injection. J. Pharm. Biomed. Anal. 41: 1458-1462.
45. United States Pharmacopeia. 3/ed., 2008. Rockville, MD: United States Pharmacopeia Convention.
46. Uyar, B., M. Celebier, and S. Altinoz. 2007. Spectrophotometric determination of rosuvastatin calcium in tablets. Pharmazie. 62: 411-413.
47. Vittal, S., R. S. Nikhil, T. R. Kumar, M. C. A. Vinu, R. Mullangi, and N. R. Srinivas. 2006. Simultaneous quantitation of rosuvastatin and gemfibrozil in human plasma by high-performance liquid chromatography and its application to a pharmacokinetic study. Biomed. Chromatogr. 20: 1252-1259.
48. Xu, D., R. Zou-Rong, Q. Zhou, H. Yuan, and B. Jiang. 2006. Quantitative determination of rosuvastatin in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20: 2369-2375.
49. Zarghi, A., S. Alireza, F. S. Mohsen, and K. Arash. 2005. A simple and rapid HPLC method for the determination of atorvastatin in human plasma with UV detection and its application to pharmacokinetic studies. Arzneim. Forsch.55: 451-454.
50. Zhu, Z., and L. Neirinck. 2003. High-performance liquid chromatography coupled with negative ion tandem mass spectrometry for determination of pravastatin in human plasma. J. Chromatogr. B 783: 133-140.